|
1
|
Yager LM, Garcia AF, Wunsch AM and
Ferguson SM: The ins and outs of the striatum: Role in drug
addiction. Neuroscience. 301:529–541. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jones CM, Logan J, Gladden RM and Bohm MK:
Vital signs: Demographic and substance use trends among heroin
users - United States, 2002–2013. MMWR Morb Mortal Wkly Rep.
64:719–725. 2015.PubMed/NCBI
|
|
3
|
Wang R, Ding Y, Bai H, et al: Illicit
heroin and methamphetamine use among methadone maintenance
treatment patients in dehong prefecture of Yunnan province, China.
PloS one. 10:e01334312015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang R, Ding Y, Bai H, Duan S, Ye R, Yang
Y, Wang J, Tang R, Gao M and He N: Illicit heroin and
methamphetamine use among methadone maintenance treatment patients
in dehong prefecture of yunnan province, China. PLoS One.
10:e01334312015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Guerrero M, Urbano M, Brown SJ, Cayanan C,
Ferguson J, Cameron M, Devi LA, Roberts E and Rosen H: Optimization
and characterization of an opioid kappa receptor (OPRK1)
antagonistProbe Reports from the NIH Molecular Libraries Program.
Bethesda (MD): 2010
|
|
6
|
Nielsen DA, Yuferov V, Hamon S, Jackson C,
Ho A, Ott J and Kreek MJ: Increased OPRM1 DNA methylation in
lymphocytes of methadone-maintained former heroin addicts.
Neuropsychopharmacology. 34:867–873. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Faisal M, Waseem D, Ismatullah H and Taqi
MM: A molecular prospective provides new insights into implication
of PDYN and OPRK1 genes in alcohol dependence. Comput Biol Med.
53:250–257. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang SC, Tsou HH, Chung RH, Chang YS, Fang
CP, Chen CH, Ho IK, Kuo HW, Liu SC, Shih YH, et al: The association
of genetic polymorphisms in the κ-opioid receptor 1 gene with body
weight, alcohol use, and withdrawal symptoms in patients with
methadone maintenance. J Clin Psychopharmacol. 34:205–211. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jablonka E: Epigenetic variations in
heredity and evolution. Clin Pharmacol Ther. 92:683–688. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Smith ZD and Meissner A: DNA methylation:
Roles in mammalian development. Nat Rev Genet. 14:204–220. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jeltsch A and Jurkowska RZ: New concepts
in DNA methylation. Trends Biochem Sci. 39:310–318. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Branco MR, Ficz G and Reik W: Uncovering
the role of 5-hydroxymethylcytosine in the epigenome. Nat Rev
Genet. 13:7–13. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kinney SR and Pradhan S: Regulation of
expression and activity of DNA (cytosine-5) methyltransferases in
mammalian cells. Prog Mol Biol Transl Sci. 101:311–333. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cadet JL, Brannock C, Jayanthi S and
Krasnova IN: Transcriptional and epigenetic substrates of
methamphetamine addiction and withdrawal: Evidence from a
long-access self-administration model in the rat. Mol Neurobiol.
51:696–717. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jayanthi S, McCoy MT, Chen B, Britt JP,
Kourrich S, Yau HJ, Ladenheim B, Krasnova IN, Bonci A and Cadet JL:
Methamphetamine downregulates striatal glutamate receptors via
diverse epigenetic mechanisms. Biol Psychiatry. 76:47–56. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Krasnova IN, Chiflikyan M, Justinova Z,
McCoy MT, Ladenheim B, Jayanthi S, Quintero C, Brannock C, Barnes
C, Adair JE, et al: CREB phosphorylation regulates striatal
transcriptional responses in the self-administration model of
methamphetamine addiction in the rat. Neurobiol Dis. 58:132–143.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Robison AJ and Nestler EJ: Transcriptional
and epigenetic mechanisms of addiction. Nat Rev Neurosci.
12:623–637. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
McQuown SC and Wood MA: Epigenetic
regulation in substance use disorders. Curr Psychiatry Rep.
12:145–153. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu X, Ji H, Liu G, Wang Q, Liu H, Shen W,
Li L, Xie X, Zhou W and Duan S: A significant association between
BDNF promoter methylation and the risk of drug addiction. Gene.
584:54–59. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
American Psychiatric Association:
Diagnostic and Statistical Manual of Mental Disorders. 4th edition.
American Psychiatric Association; Washington, DC: 1994
|
|
21
|
Shen W, Liu Y, Li L, Zhang Y and Zhou W:
Negative moods correlate with craving in female methamphetamine
users enrolled in compulsory detoxification. Subst Abuse Treat Prev
Policy. 7:442012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kreutz M, Hochstein N, Kaiser J, Narz F
and Peist R: Pyrosequencing: Powerful and quantitative sequencing
technology. Curr Protoc Mol Biol. 104:Unit 7.15. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chang L, Wang Y, Ji H, Dai D, Xu X, Jiang
D, Hong Q, Ye H, Zhang X, Zhou X, et al: Elevation of peripheral
BDNF promoter methylation links to the risk of Alzheimer's disease.
PLoS One. 9:e1107732014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Edenberg HJ, Wang J, Tian H, Pochareddy S,
Xuei X, Wetherill L, Goate A, Hinrichs T, Kuperman S, Nurnberger JI
Jr, et al: A regulatory variation in OPRK1, the gene encoding the
kappa-opioid receptor, is associated with alcohol dependence. Hum
Mol Genet. 17:1783–1789. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ji H, Wang Y, Liu G, Xu X, Dai D, Chen Z,
Zhou D, Zhou X, Han L, Li Y, et al: OPRK1 promoter hypermethylation
increases the risk of Alzheimer's disease. Neurosci Lett.
606:24–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gharagozlou P, Hashemi E, DeLorey TM,
Clark JD and Lameh J: Pharmacological profiles of opioid ligands at
kappa opioid receptors. BMC Pharmacol. 6:32006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Klous MG, Van den Brink W, Van Ree JM and
Beijnen JH: Development of pharmaceutical heroin preparations for
medical co-prescription to opioid dependent patients. Drug Alcohol
Depend. 80:283–295. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bruchas MR, Xu M and Chavkin C: Repeated
swim stress induces kappa opioid-mediated activation of
extracellular signal-regulated kinase 1/2. Neuroreport.
19:1417–1422. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wen S, Wang C, Berg A, Li Y, Chang MM,
Fillingim RB, Wallace MR, Staud R, Kaplan L and Wu R: Modeling
genetic imprinting effects of DNA sequences with multilocus
polymorphism data. Algorithms Mol Biol. 4:112009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Levran O, Londono D, O'Hara K, Nielsen DA,
Peles E, Rotrosen J, Casadonte P, Linzy S, Randesi M, Ott J, et al:
Genetic susceptibility to heroin addiction: A candidate gene
association study. Genes Brain Behav. 7:720–729. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gerra G, Leonardi C, Cortese E, D'Amore A,
Lucchini A, Strepparola G, Serio G, Farina G, Magnelli F, Zaimovic
A, et al: Human kappa opioid receptor gene (OPRK1) polymorphism is
associated with opiate addiction. Am J Med Genet B Neuropsychiatr
Genet. 144B:771–775. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Black SM, Ellard S, Meehan RR, Parry JM,
Adesnik M, Beggs JD and Wolf CR: The expression of cytochrome
P450IIB1 in Saccharomyces cerevisiae results in an increased
mutation frequency when exposed to cyclophosphamide.
Carcinogenesis. 10:2139–2143. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schenk S, Partridge B and Shippenberg TS:
U69593, a kappa-opioid agonist, decreases cocaine
self-administration and decreases cocaine-produced drug-seeking.
Psychopharmacology (Berl). 144:339–346. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mash DC and Staley JK: D3 dopamine and
kappa opioid receptor alterations in human brain of
cocaine-overdose victims. Ann N Y Acad Sci. 877:507–522. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gossop M, Griffiths P, Powis B, Williamson
S and Strang J: Frequency of non-fatal heroin overdose: Survey of
heroin users recruited in non-clinical settings. BMJ. 313:4021996.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Darke S, Ross J, Zador D and Sunjic S:
Heroin-related deaths in New South Wales, Australia, 1992–1996.
Drug Alcohol Depend. 60:141–150. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Darke S and Zador D: Fatal heroin
‘overdose’: A review. Addiction. 91:1765–1772. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Scott JC, Woods SP, Matt GE, Meyer RA,
Heaton RK, Atkinson JH and Grant I: Neurocognitive effects of
methamphetamine: A critical review and meta-analysis. Neuropsychol
Rev. 17:275–297. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cruickshank CC and Dyer KR: A review of
the clinical pharmacology of methamphetamine. Addiction.
104:1085–1099. 2009. View Article : Google Scholar : PubMed/NCBI
|
